Xtant Medical Holdings, Inc. (XTNT): Daniel S Goldberger , CEO of Xtant Medical Holdings, Inc. purchased 5,000 shares on May 9, 2016. The Insider buying transaction was reported by the company on May 10, 2016 to the Securities and Exchange Commission. The shares were purchased at $2.34 per share for a total value of $11,700.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Dec 3, 2015, Kent L Swanson (director) purchased 3,300 shares at $2.83 per share price.On Nov 23, 2015, David Louis Kirschman (director officer 10% owner (EVP & Chief Scientifi) purchased 2,000 shares at $2.99 per share price.Also, On Nov 16, 2015, Daniel S Goldberger (CEO) purchased 3,000 shares at $2.80 per share price.
Bacterin International Holdings Inc. is engaged in developing manufacturing and marketing biologics products to domestic and international markets. The Company’s bone graft products are used in a range of applications including enhancing fusion in spine surgery relief of back pain through facet joint stabilization promotion of bone growth in foot and ankle surgery promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries. The Company’s acellular dermis scaffolds are utilized in wound care and plastic and reconstructive procedures. The Company also develops custom surgical instruments for use with its allografts. The Company’s products include OsteoSponge OsteoSponge SC OsteoSelect DBM putty OsteoWrap OsteoLock BacFast HD OsteoSTX hMatrix and its line of 3Demin products as well as other allograft products.